Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: promising but inconclusive evidence of superiority, compared with antimony monotherapy.
Ojha
Rohit P
RP
Cervantes
Diana
D
Fischbach
Lori A
LA
D000284:Administration, Oral; D000965:Antimony / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007896:Leishmaniasis / Q000188:drug therapy*; D010431:Pentoxifylline / Q000627:therapeutic use*
D000965:Antimony; D010431:Pentoxifylline